We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Hafiz Algurafi at Spire include:
I have been a consultant clinical oncologist for six years. I trained in both chemotherapy and radiotherapy at the Royal Marsden, Charing Cross and Hammersmith and Guys and St Thomas Hospitals. My area of interest and expertise is treatment of breast, gynaecological and skin cancers.
I specialise in the Chemotherapy and Radiotherapy treatment of breast, gynaecological and skin cancers. I am Breast and Gynaecology Research Lead and am totally dedicated to providing the most up to date treatments in both Chemotherapy and Radiotherapy.
I assess and treat in both my NHS and private practice approximately 120 patients per week and have treated approximately 1,500 breast cancer patients, 500 gynaecological and 750 skin cancer patients over the last five years.
I am Southend University Hospital Breast and Gynaecological research lead and have been Principle Investigator in over 25 trials. I am also Chair of the Chemotherapy Mortality group.
Southend University Hospital Breast and Gynaecology Cancer Research Lead
Consultant Clinical Oncologist, Southend University Hospital NHS Trust and Basildon and Thurrock University Hospital NHS TrustBack to top
I am married with two sons, enjoy travelling, walking and the cinema.Back to top
|Telephone||Spire Wellesley Insured patients: 01702 447921 Spire Wellesley Self Pay Patients: 01702 447926 or Spire Hartswood: 01277 266 766|
|Private secretary||Lynne Richards|
|Private secretary telephone||01245 400 764|
|Private secretary email@example.com|
09 December 2019
West Midlands-based Spire Parkway Hospital has been upgraded to a ‘Good’ rating, following an inspection by the Care Qua…
04 December 2019
Spire Southampton has retained its ‘Good’ rating following an inspection by the Care Quality Commission (CQC).